Top Markets
Coin of the day
Pharmadrug Inc. Pharmadrug Inc.

Pharmadrug Inc.

PHRX
株式のランク #38427
Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to... Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to the research, development, and market introduction of controlled substances and natural therapeutics, such as psychedelics, cannabis, and other approved compounds derived from nature. The company also manages the import and supply of medical cannabis to pharmacies across Germany and the broader European Union. Additionally, it operates Super Smart, an entity focused on advancing the application of functional and psilocybin mushrooms, and engages in studies to reformulate established natural medicines. Pharmadrug maintains key research collaborations, including an agreement with the University of Michigan to explore the potential role of N, N-dimethyltryptamine (DMT) in various states of consciousness. It has also partnered with the Southwest Research Institute for the manufacturing of cepharanthine and entered into a clinical trial agreement with Johns Hopkins University to compare the acute and enduring psychological and neural effects of DMT against another potent active molecule. The company adopted its current name in October 2019, having previously operated as Aura Health Inc.
株価
$0.00733937
時価総額
$985.05K
変化(1日)
0.00%
変化(1年)
-32.41%
CA
取引 Pharmadrug Inc. (PHRX)

カテゴリー

Pharmadrug Inc.(PHRX)の利益
2026 時点の利益 TTM: 0
Pharmadrug Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Pharmadrug Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。